Kestra Private Wealth Services, LLC Arcutis Biotherapeutics, Inc. Transaction History
Kestra Private Wealth Services, LLC
- $5.74 Billion
- Q1 2025
A detailed history of Kestra Private Wealth Services, LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Kestra Private Wealth Services, LLC holds 14,158 shares of ARQT stock, worth $207,273. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,158Holding current value
$207,273% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARQT
# of Institutions
250Shares Held
126MCall Options Held
605KPut Options Held
170K-
Suvretta Capital Management, LLC New York, NY11.4MShares$167 Million7.82% of portfolio
-
Jennison Associates LLC11.4MShares$166 Million0.13% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$161 Million4.91% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$129 Million8.65% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$126 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $881M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...